This is a preprint.
Disulfide bonds are required for cell division, cell envelope biogenesis and antibiotic resistance proteins in mycobacteria
- PMID: 39975046
- PMCID: PMC11838256
- DOI: 10.1101/2025.01.27.635063
Disulfide bonds are required for cell division, cell envelope biogenesis and antibiotic resistance proteins in mycobacteria
Update in
-
Disulfide bonds are critical for stabilizing cell division, cell envelope biogenesis, and antibiotic resistance proteins in mycobacteria.mBio. 2025 Sep 10;16(9):e0108325. doi: 10.1128/mbio.01083-25. Epub 2025 Jul 31. mBio. 2025. PMID: 40741763 Free PMC article.
Abstract
Mycobacteria, including Mycobacterium tuberculosis-the etiological agent of tuberculosis-have a unique cell envelope critical for their survival and resistance. The cell envelope's assembly and maintenance influence permeability, making it a key target against multidrug-resistant strains. Disulfide bond (DSB) formation is crucial for the folding of cell envelope proteins. The DSB pathway in mycobacteria includes two enzymes, DsbA and VKOR, required for survival. Using bioinformatics and cysteine profiling proteomics, we identified cell envelope proteins dependent on DSBs. We validated via in vivo alkylation that key proteins like LamA (MmpS3), PstP, LpqW, and EmbB rely on DSBs for stability. Furthermore, chemical inhibition of VKOR results in phenotypes similar to those of Δvkor. Thus, targeting DsbA-VKOR systems could compromise both cell division and mycomembrane integrity. These findings emphasize the potential of DSB inhibition as a novel strategy to combat mycobacterial infections.
Keywords: AftB; AftD; DsbA; EccB3; EmbB; LamA; LpqW; MmpS3; MycP3; PP2C; PstP; Rv2507; Ser/Thr phosphatase; VKOR; actinobacteria; disulfide bonds; essential proteins; mycobacteria; mycomembrane; oxidative protein folding; substrates.
Conflict of interest statement
Conflict of Interest The authors declare no conflict of interest.
Figures





References
-
- Global tuberculosis report. Global Tuberculosis Report 2021. (World Health Organization, 2021).
-
- CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC. Antibiotic Resistance Threats in the United States, 2019. https://stacks.cdc.gov/view/cdc/82532 (2019) doi: 10.15620/cdc:82532. - DOI
-
- Mirabal A., F. G. B., A. N. Lung Nontuberculous Mycobacterial Infections. (2024).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources